Research - News
This study was done in mice and with a novel, tissue-engineered, three-dimensional breast cancer mimetic system.
This mouse study looked at a group of immune cells called innate-like B-1 B cells.
Genetic assessments can help predict the risk of common diseases, and UAB is part of a national study to better understand and implement polygenic risk scores
In partnership with community members, researchers at UAB created the first culturally based protocol for patients living with a serious illness or facing end-of-life care.
Higher-volume feedings were determined to help postnatal growth in preterm infants.
In a study led by a UAB neonatologist, findings showed that racial and ethnic disparities in preterm infants decreased.
Exercise is good for you, but how does affect the very building blocks of your body? UAB is poised to find out.
Doctors at UAB are now able to safely transplant organs from hepatitis C-positive donors into uninfected recipients and then treat the patients with antiviral therapy.
Injections of two chemicals in a slow-release form significantly reduced the size of dead heart tissue and improved the function of the left ventricle.
This novel finding will enable experimental studies to determine whether and how these microbes play a role in triggering the disease.
Researchers from UAB are working with the NIH and Bill & Melinda Gates Foundation to study a potential antibiotic to treat maternal and infant sepsis in low-income countries.
New evidence for sex disparity in liver transplants suggests a change may be needed in how livers are allocated.
A mouse model and previous studies suggest that genetic intervention in SHANK3-related ASD may be most effective earlier in development.
UAB’s CCTS joins a nationwide collaboration creating a secure, central database of electronic health records from coronavirus patients.
A grant from the NICHD will help study hepatitis B transmission in African newborns.
Results show that retinitis pigmentosa 59 may not be a congenital disorder of glycosylation, as was long assumed.
Everyone was fast this spring: the businesses that contributed to the fund, the scientists and physicians who crafted research proposals, and the senior School of Medicine researchers who chose which proposals got money.
The results will demonstrate where the novel coronavirus has spread undetected in the United States and provide insights into the types of populations that are most affected.
AMPLIFY and DUET provide sound information and support to make changes in diet and physical activity that are key in keeping cancer survivors and their loved ones healthy.
UAB moved its premiere undergraduate research event online during the pandemic.
Mieke Beth Thomeer, Ph.D., and Jenjira Yahirun, Ph.D., discuss how families influence health and health disparities throughout life’s course and during COVID-19.
While demand for medical cannabis products grows in the United States, a UAB study suggests health care providers are ill-equipped to provide guidance.
The complement system is part of the body’s immune system to fight pathogens and remove cell debris. Its role in two autoimmune diseases and a mental disorder is a surprise.
A new rapid sexually transmitted infection test developed through research done at UAB will help diagnose and treat patients in real time moving forward.
Dual antiplatelet therapy after percutaneous coronary intervention uses aspirin and one other drug, among several choices. But which drug is best to use?
This discovery may have clinical importance in management of heart failure.
Amid the ongoing coronavirus pandemic, UAB students developed a project to help inform the Birmingham community and beyond.
A study conducted by UAB investigators has outlined the importance of strict blood pressure control in the development of atrial fibrillation, which can lead to poor outcomes such as stroke, heart attacks and death.
A microbiome “fingerprint” method allows tracking of mothers’ microbial strains inherited by infants.
This is thought to be the first time that information found via artificial intelligence has led to a clinical trial.